Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Cereol89 , Velvet, CC BY-SA 4.0, Wikimedia Commons
Vous êtes Dr Peggy Philippe ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Peggy Philippe est rhumatologue à Lille (59037). Il consulte à HÔPITAL SALENGRO CHU LILLE, CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille.
Consulter
HÔPITAL SALENGRO CHU LILLE
CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille
Hospitalier
Dr Peggy Philippe, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2014JAMA577 citations
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial
2011Radiology60 citations
Use of tomosynthesis for erosion evaluation in rheumatoid arthritic hands and wrists
2014PloS one42 citations
Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach
En bref
Dr Peggy Philippe consulte à HÔPITAL SALENGRO CHU LILLE, CITE HOSPITALIERE — Rue EMILE LAINE, 59037 Lille. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 03 20 44 59 62 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Lille, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
2024Rheumatology (Oxford, England)PubMed
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study
2019American journal of therapeuticsPubMed
Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis
2017Clinical rheumatologyPubMed
Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study
2016International journal of rheumatic diseasesPubMed
Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study
2015Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of AmyloidosisPubMed
AA amyloidosis treated with tocilizumab: case series and updated literature review
2012Joint bone spinePubMed
Efficacy of rituximab in the treatment of rheumatoid arthritis. Influence of serologic status, coprescription of methotrexate and prior TNF-alpha inhibitors exposure
2024Joint bone spinePubMed
Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study
2022Joint bone spinePubMed
Treatment persistence of tumour necrosis factors and IL-17 inhibitors in axial spondyloarthritis: A multi-center comparative analysis
2017The Journal of rheumatologyPubMed
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases
2015The Journal of rheumatologyPubMed
Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome
2011Rheumatology (Oxford, England)PubMed
Efficacy in current practice of switching between anti-tumour necrosis factor- α agents in spondyloarthropathies
2019American journal of therapeuticsPubMed
Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis
2015TheranosticsPubMed
Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response
2014PloS onePubMed
Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach
2012Joint bone spinePubMed
Efficacy of rituximab in the treatment of rheumatoid arthritis. Influence of serologic status, coprescription of methotrexate and prior TNF-alpha inhibitors exposure
2026Rheumatology (Oxford, England)PubMed
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas
2023Seminars in arthritis and rheumatismPubMed
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
2021Rheumatology (Oxford, England)PubMed
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison
2020The Journal of rheumatologyPubMed
Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study
2010Joint bone spinePubMed
Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases
2007Presse medicale (Paris, France : 1983)PubMed
[Autoimmune hemolytic anemia: diagnosis and management]
2007La Revue de medecine internePubMed
[Nodular thrombophlebitis and granulomatous systemic disease]
1993NeuroepidemiologyPubMed
Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity
2017Joint bone spinePubMed
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab
2014PloS onePubMed
Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach
2026 · Article
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas
2025 · Article
Élaboration par consensus d’experts d’une liste des thématiques d’information du patient à aborder lors de la dispensation d’une thérapie ciblée pour un patient atteint d’un rhumatisme inflammatoire en pharmacie d’officine
2024 · Article
Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study
2024 · Article
Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study
2023 · Article
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
2023 · Article
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
2022 · Article
Lack of Association between the TNFAIP3 Rs2230926 Variant and Rheumatoid Arthritis-Associated Lymphoma.
2021 · Article
Lymphoma complicating rheumatoid arthritis: results from a French casecontrol study
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.